NEW: We've expanded Stock Detail, Screener, and Maps with new data

Stock Detail, Screener:
3, 5, 10-Year Performance
EV/EBITDA, EV/Sales
Dividend Growth (1, 3, 5 Years)
EPS & Sales Growth (3 Years)

Maps:
All from Screener plus:
ROA, ROE, ROIC
Quick & Current Ratios
LT Debt and Debt to Equity Ratios
Gross, Operating, and Net Margins

Last Close
Jul 08 03:54PM ET
1.75
Dollar change
+0.12
Percentage change
7.67
%
Index- P/E- EPS (ttm)-1.13 Insider Own13.30% Shs Outstand45.77M Perf Week65.57%
Market Cap80.32M Forward P/E- EPS next Y-0.08 Insider Trans0.00% Shs Float39.68M Perf Month150.00%
Enterprise Value80.33M PEG- EPS next Q-0.04 Inst Own8.65% Short Float3.50% Perf Quarter387.64%
Income-33.23M P/S4.61 EPS this Y41.11% Inst Trans105.81% Short Ratio0.70 Perf Half Y290.00%
Sales17.42M P/B4.63 EPS next Y82.54% ROA-73.58% Short Interest1.39M Perf YTD326.28%
Book/sh0.38 P/C9.00 EPS next 5Y- ROE-121.65% 52W High1.68 4.46% Perf Year75.50%
Cash/sh0.19 P/FCF- EPS past 3/5Y-32.14% -11.23% ROIC-132.36% 52W Low0.27 550.00% Perf 3Y-53.82%
Dividend Est.- EV/EBITDA- Sales past 3/5Y9.90% 16.96% Gross Margin40.19% Volatility13.73% 17.25% Perf 5Y-71.23%
Dividend TTM- EV/Sales4.61 EPS Y/Y TTM-169.29% Oper. Margin-60.26% ATR (14)0.15 Perf 10Y-
Dividend Ex-Date- Quick Ratio2.11 Sales Y/Y TTM-0.71% Profit Margin-190.81% RSI (14)87.03 Recom1.00
Dividend Gr. 3/5Y- - Current Ratio2.32 EPS Q/Q-447.09% SMA2074.42% Beta0.47 Target Price4.07
Payout- Debt/Eq0.51 Sales Q/Q-5.89% SMA50147.87% Rel Volume1.31 Prev Close1.63
Employees101 LT Debt/Eq0.45 EarningsMar 28 BMO SMA200233.99% Avg Volume1.97M Price1.75
IPONov 06, 2003 Option/ShortYes / Yes EPS/Sales Surpr.-726.70% -12.02% Trades Volume2,537,891 Change7.67%
Date Action Analyst Rating Change Price Target Change
Dec-02-22Initiated H.C. Wainwright Buy $9
Oct-25-21Initiated The Benchmark Company Buy $12
Jul-07-25 09:00AM
Jul-06-25 04:01AM
Jul-03-25 08:19AM
Jun-24-25 07:02AM
Jun-12-25 08:01AM
08:01AM Loading…
Jun-05-25 08:01AM
May-21-25 08:49AM
May-20-25 08:28AM
May-12-25 08:01AM
Apr-11-25 08:40AM
Apr-03-25 12:00PM
Mar-28-25 12:59PM
09:15AM
08:01AM
Mar-27-25 05:50PM
07:02AM Loading…
Mar-13-25 07:02AM
Mar-11-25 10:17PM
Mar-05-25 08:01AM
Feb-26-25 08:01AM
Feb-24-25 08:01AM
Feb-20-25 08:01AM
Jan-27-25 08:01AM
Jan-23-25 07:15AM
Jan-22-25 07:02AM
Jan-17-25 08:01AM
Jan-02-25 02:55AM
Dec-31-24 07:56PM
Dec-23-24 08:30AM
Dec-19-24 10:15AM
Dec-10-24 08:30AM
08:00AM Loading…
Dec-04-24 08:00AM
Dec-03-24 08:30AM
Nov-27-24 07:00AM
Nov-13-24 09:00AM
Nov-04-24 08:01AM
Oct-28-24 07:30AM
Oct-21-24 09:00AM
Oct-10-24 08:10AM
Oct-09-24 03:21PM
Oct-02-24 08:00AM
Sep-26-24 09:00AM
Sep-16-24 09:00AM
Sep-13-24 09:01AM
Sep-09-24 09:11AM
Aug-26-24 09:00AM
Aug-23-24 08:00PM
Aug-19-24 09:00AM
Jul-29-24 08:30AM
Jul-23-24 07:30PM
Jul-16-24 08:01PM
Jul-15-24 08:31AM
Jun-27-24 08:01AM
Jun-25-24 07:02AM
Jun-12-24 07:00AM
Jun-10-24 07:15AM
Jun-04-24 07:00AM
Apr-22-24 09:00AM
Apr-12-24 09:00AM
Mar-28-24 07:02AM
Mar-20-24 07:02AM
Mar-15-24 01:48PM
Mar-14-24 12:52PM
09:30AM
08:05AM
Mar-08-24 08:30AM
Mar-07-24 07:02AM
Mar-04-24 08:01AM
Feb-13-24 08:35AM
Jan-10-24 09:00AM
Dec-19-23 08:18AM
Dec-14-23 01:51PM
08:01AM
Dec-08-23 05:00PM
Dec-07-23 09:00AM
Dec-06-23 09:00AM
07:00AM
Dec-05-23 04:35PM
Nov-27-23 08:01AM
Nov-22-23 09:00AM
Nov-13-23 08:32AM
Oct-25-23 08:01AM
Oct-23-23 08:01AM
Oct-20-23 09:00AM
Oct-13-23 09:45AM
Oct-11-23 09:55AM
Sep-19-23 08:01AM
Sep-14-23 08:00AM
Sep-08-23 08:30AM
Sep-05-23 08:00AM
Aug-09-23 09:15AM
Jul-14-23 08:10AM
Jul-07-23 08:10AM
Jun-29-23 09:00AM
Jun-16-23 09:30AM
Jun-13-23 07:38AM
Jun-06-23 08:04AM
May-30-23 08:04AM
May-17-23 08:04AM
Mar-30-23 08:04AM
Mar-27-23 08:49AM
ImmunoPrecise Antibodies Ltd. is a techbio company that leverages multi-omics modeling and complex artificial intelligence through a series of proprietary and patented technologies. It owns an integrated end-to-end suite of capabilities to support the development of therapeutic antibodies and are known for solving very complex industry challenges. The company was founded by Robert Beecroft on November 22, 1983 and is headquartered in Austin, TX.